Want to see SG:569 full AI Analyst Report?
569 Stock Chart & Stats
S$0.07
S$0.00(0.00%)
At close: 4:00 PM EDT
S$0.07
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.10
Previous CloseN/A
Volume4.90K
Average Volume (3M)48.44K
Market Cap
S$35.78M
Enterprise ValueS$78.28M
Total Cash (Recent Filing)S$6.51M
Total Debt (Recent Filing)S$43.91M
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Sep 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.24%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding511,537,700
10 Day Avg. Volume20,300
30 Day Avg. Volume48,440
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.38
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
2025 Revenue ReboundThe sharp 2025 top-line recovery indicates renewed demand or improved commercial execution. If sustained, higher revenue can improve operating leverage and provide a stronger base for restoring profitability over the next several reporting periods.
Healthy Gross MarginsGross margins above 50% demonstrate that the core product economics retain meaningful value despite recent losses. This margin base gives management room to address operating costs and potentially convert revenue growth into sustainable earnings.
Substantial Equity CushionA sizable equity base provides balance-sheet support and reduces immediate solvency pressure while the business works through weaker profitability. This cushion can preserve financial flexibility, although leverage trends still require monitoring.
Bears Say
Persistent Net LossesRecent revenue growth has not yet translated into positive bottom-line earnings. Continued losses weaken retained capital and indicate that operating costs or other charges remain too high for the current revenue base, limiting earnings durability.
Weak Cash ConversionVery low operating cash flow and negative free cash flow constrain internal funding for operations and investment. Persistent weak conversion can increase reliance on external financing and makes the revenue rebound less valuable until cash generation improves.
Rising LeverageThe upward leverage trend signals greater reliance on debt at a time when profitability and cash generation are weak. Higher financing commitments could reduce flexibility and amplify balance-sheet risk if losses or negative free cash flow persist.
VicPlas International Ltd. News
569 FAQ
What was VicPlas International Ltd.’s price range in the past 12 months?
VicPlas International Ltd. lowest share price was S$0.07 and its highest was S$0.10 in the past 12 months.
What is VicPlas International Ltd.’s market cap?
VicPlas International Ltd.’s market cap is S$35.78M.
When is VicPlas International Ltd.’s upcoming earnings report date?
VicPlas International Ltd.’s upcoming earnings report date is Sep 25, 2026 which is in 10 days.
How were VicPlas International Ltd.’s earnings last quarter?
VicPlas International Ltd. released its earnings results on Mar 13, 2026. The company reported -S$0.007 earnings per share for the quarter.
Is VicPlas International Ltd. overvalued?
According to Wall Street analysts VicPlas International Ltd.’s price is currently Overvalued.
Does VicPlas International Ltd. pay dividends?
VicPlas International Ltd. pays a Annually dividend of S$0.004 which represents an annual dividend yield of 3.24%. See more information on VicPlas International Ltd. dividends here
What is VicPlas International Ltd.’s EPS estimate?
VicPlas International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VicPlas International Ltd. have?
VicPlas International Ltd. has 511,537,700 shares outstanding.
What happened to VicPlas International Ltd.’s price movement after its last earnings report?
VicPlas International Ltd. reported an EPS of -S$0.007 in its last earnings report. Following the earnings report the stock price went down -1.124%.
Which hedge fund is a major shareholder of VicPlas International Ltd.?
Currently, no hedge funds are holding shares in SG:569
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VicPlas International Ltd.
Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Republic of China, and the United Kingdom. Its piping division focuses on the manufacturing, trading, and distribution of a variety of piping solutions. These systems are utilized for diverse applications such as waste and potable water management in residential, educational, commercial, and industrial settings; conduits for underground electrical and internal building wiring; and data and signal lines for telecommunication providers. Additionally, Vicplas is engaged in the design, development, production, and assembly of both sterile and non-sterile medical devices. The company also offers specialized project design and engineering services. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Technical Analysis
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
AJJ Medtech Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―